Literature DB >> 6321534

Endocrine functioning in multitransfused prepubertal patients with homozygous beta-thalassemia.

A Masala, T Meloni, D Gallisai, S Alagna, P P Rovasio, S Rassu, A F Milia.   

Abstract

Endocrine function was evaluated in 20 prepubertal patients with homozygous beta-thalassemia treated with frequent transfusions and long term iron chelation therapy. FSH, LH, PRL, and TSH secretion were evaluated by LRH and TRH testing and L-dopa and ACTH were used to assess GH and adrenocortical reserve. No statistically significant differences were found between FSH, LH, PRL, GH, and cortisol secretion in the patients and in normal subjects. There was a relatively high incidence (35%) of primary thyroid impairment since 1 patient had primary hypothyroidism and 6 others had evidence of subclinical hypothyroidism as manifested by increased TSH responses to TRH. However, no statistically significant correlations were found between either serum ferritin levels, total blood transfusions received, and thyroid function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321534     DOI: 10.1210/jcem-58-4-667

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Adrenal glands in beta-thalassemia major: magnetic resonance (MR) imaging features and correlation with iron stores.

Authors:  Eleni Drakonaki; Olympia Papakonstantinou; Thomas Maris; Artemis Vasiliadou; Alex Papadakis; Nicholas Gourtsoyiannis
Journal:  Eur Radiol       Date:  2005-08-16       Impact factor: 5.315

2.  High prevalence of thyroid dysfunction in adult patients with beta-thalassemia major submitted to amiodarone treatment.

Authors:  S Mariotti; A Loviselli; S Murenu; F Sau; L Valentino; A Mandas; S Vacquer; E Martino; A Balestrieri; M E Lai
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

Review 3.  Growth and endocrine function in thalassemia major in childhood and adolescence.

Authors:  M Delvecchio; L Cavallo
Journal:  J Endocrinol Invest       Date:  2010-01       Impact factor: 4.256

4.  Growth hormone response following growth hormone releasing hormone injection in thalassemia major: influence of pubertal development.

Authors:  B P Leheup; M Cisternino; M Bozzola; B Dousset; P L Marradi; F Antoniazzi; L Tato; F Severi; D Sommelet; M Pierson
Journal:  J Endocrinol Invest       Date:  1991-01       Impact factor: 4.256

5.  Evaluation of hypothalamic-pituitary function in patients with thalassemia major.

Authors:  L Danesi; M Scacchi; M De Martin; A Dubini; P Massaro; A T Majolo; F Cavagnini; E E Polli
Journal:  J Endocrinol Invest       Date:  1992-03       Impact factor: 4.256

6.  Growth hormone secretion in polytransfused prepubertal patients with homozygous beta-thalassemia. Effect of long-term recombinant GH (recGH) therapy.

Authors:  A Masala; M M Atzeni; S Alagna; D Gallisai; C Burrai; M G Mela; P P Rovasio; P Gallo
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

7.  Relationship of endocrinopathy to iron chelation status in young patients with thalassaemia major.

Authors:  R G Grundy; K A Woods; M O Savage; J P Evans
Journal:  Arch Dis Child       Date:  1994-08       Impact factor: 3.791

8.  Effect of human chorionic gonadotropin on growth velocity and biological growth parameters in adolescents with thalassaemia major.

Authors:  M Bozzola; J Argente; M Cisternino; A Moretta; A Valtorta; I Biscaldi; M Donnadieu; D Evain-Brion; F Severi
Journal:  Eur J Pediatr       Date:  1989-01       Impact factor: 3.183

9.  Circadian growth hormone secretion in short multitransfused prepubertal children with thalassaemia major.

Authors:  G Katzos; F Harsoulis; M Papadopoulou; M Athanasiou; K Sava
Journal:  Eur J Pediatr       Date:  1995-06       Impact factor: 3.183

10.  Thyroid function status and echocardiographic abnormalities in patients with Beta thalassemia major in bahrain.

Authors:  Taysir S Garadah; Najat A Mahdi; Ahmed M Jaradat; Zuheir A Hasan; Das S Nagalla
Journal:  Clin Med Insights Cardiol       Date:  2013-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.